Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

452
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
452
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
210
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

445
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
445
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

212
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Health Outcomes Following Traumatic Brain Injury: An Umbrella Review.

Neuropsychology review·2026
Same author

The utility of the Australian primary health networks' initial assessment and referral decision support tool (IAR-DST) for cross-sectional assessment of care needs in young adults attending a tertiary community mental health service.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same author

Bulk Flow of Cerebrospinal Fluid in the Cervicothoracic Spine.

AJNR. American journal of neuroradiology·2026
Same author

Traumatic brain injury and post-traumatic stress disorder on brain imaging markers and cognition in a war veterans population.

Journal of Alzheimer's disease : JAD·2026
Same author

Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo  1H-MR Spectroscopy.

Neuro-oncology·2026
Same author

Podium Abstracts Presented at the 2025 Annual Meeting of the Arthroscopy Association of North America.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2026

相关实验视频

Updated: Jul 16, 2025

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.4K

大脑谷氨的增加和发作负担的降低在基因饮食中的患者.

Saman Hazany1, Brittany DeClouette1, Jessica Lowe2

  • 1Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Journal of epilepsy research
|September 18, 2023
PubMed
概括

性饮食显著增加了患者的大脑谷氨 (GSH) 水平. 这种GSH的增加与发作频率和持续时间的减少50%相关,这表明潜在的抗作用.

关键词:
一个小时的MRS.是一种病.这是GSHGSH.葡萄糖氨酸 (Glutathione) 是一种基因饮食是基因的饮食.在MR光谱检测中使用MR光谱.

更多相关视频

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.5K

相关实验视频

Last Updated: Jul 16, 2025

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.4K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.5K

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 的研究研究.

背景情况:

  • 耐药性是一种重大的临床挑战.
  • 性饮食 (KD) 是一种改善控制的成熟疗法.
  • 线粒体谷氨 (GSH) 水平可能会影响发作易感性.

研究的目的:

  • 通过体内1H磁共振光谱 (1H MRS) 来量化大脑中的绝对谷氨 (GSH) 水平.
  • 为了将大脑GSH水平的变化与KD药物耐药患者的控制相关联.
  • 调查GSH的潜在抗作用.

主要方法:

  • 一项试点研究涉及两名患有抗药性的成年患者.
  • 患者遵循修改后的阿特金斯饮食六个月.
  • 在灰色和白质中测量了绝对GSH水平,在基线和六个月使用1H MRS进行测量.

主要成果:

  • 两位患者在灰色和白色物质的绝对GSH水平显著增加 (观察到7倍和14倍的增加).
  • 在这两位患者中,发作持续时间和频率均有50%的改善.
  • 其他代谢物,包括体,没有显示一致的变化.

结论:

  • 大脑GSH水平的显著增加在KD上患有难治性的患者中观察到.
  • 观察到的GSH的增加与明显的发作改善相关.
  • 这项试点研究支持谷在大脑中的潜在抗作用.